Unknown

Dataset Information

Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.


ABSTRACT:

Background

The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC] plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 inhibitor) in patients with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) is unclear.

Purpose

To examine the effects of dual versus triple therapy on bleeding and ischemic outcomes in adults with AF after PCI.

Data sources

Searches of PubMed, EMBASE, and the Cochrane Library (inception to 31 December 2019) and ClinicalTrials.gov (7 January 2020) without language restrictions; journal Web sites; and reference lists.

Study selection

Randomized controlled trials that compared the effects of dual versus triple therapy on bleeding, mortality, and ischem

SUBMITTER: Khan SU 

PROVIDER: S-EPMC7489449 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature